These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 20623993)
1. Economic burden of epilepsy among the privately insured in the US. Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S Pharmacoeconomics; 2010; 28(8):675-85. PubMed ID: 20623993 [TBL] [Abstract][Full Text] [Related]
2. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US. Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010 [TBL] [Abstract][Full Text] [Related]
3. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150 [TBL] [Abstract][Full Text] [Related]
4. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541 [TBL] [Abstract][Full Text] [Related]
5. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US. Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698 [TBL] [Abstract][Full Text] [Related]
6. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160 [TBL] [Abstract][Full Text] [Related]
7. The direct and indirect costs among U.S. privately insured employees with hypogonadism. Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380 [TBL] [Abstract][Full Text] [Related]
8. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population. Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect costs associated with Dupuytren's contracture. Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346 [TBL] [Abstract][Full Text] [Related]
10. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study. Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056 [TBL] [Abstract][Full Text] [Related]
11. Burden of venous leg ulcers in the United States. Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244 [TBL] [Abstract][Full Text] [Related]
12. Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs. Birnbaum HG; Ivanova JI; Samuels S; Davis M; Cremieux PY; Phillips AL; Meletiche D Curr Med Res Opin; 2009 Apr; 25(4):869-77. PubMed ID: 19232041 [TBL] [Abstract][Full Text] [Related]
13. The economic consequences of irritable bowel syndrome: a US employer perspective. Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202 [TBL] [Abstract][Full Text] [Related]
14. Economic costs of benign prostatic hyperplasia in the private sector. Saigal CS; Joyce G J Urol; 2005 Apr; 173(4):1309-13. PubMed ID: 15758787 [TBL] [Abstract][Full Text] [Related]
15. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Wu EQ; Birnbaum HG; Mareva M; Tuttle E; Castor AR; Jackman W; Ruskin J Curr Med Res Opin; 2005 Oct; 21(10):1693-9. PubMed ID: 16238910 [TBL] [Abstract][Full Text] [Related]
16. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States. Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063 [TBL] [Abstract][Full Text] [Related]
17. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States. Fu AZ; Jhaveri M J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589 [TBL] [Abstract][Full Text] [Related]
18. Duloxetine use in chronic low back pain: treatment patterns and costs. Ivanova JI; Birnbaum HG; Kantor E; Schiller M; Swindle RW Pharmacoeconomics; 2012 Jul; 30(7):595-609. PubMed ID: 22686662 [TBL] [Abstract][Full Text] [Related]
19. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation. Parasuraman S; Thiel E; Park J; Teschemaker A J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994 [TBL] [Abstract][Full Text] [Related]
20. The economic burden of schizophrenia in the United States in 2002. Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]